Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Adenocarcinomas of the Pancreas”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableStudy completedNCT00898482
What this trial is testing

Collecting and Storing Samples of Blood From Patients With Pancreatic Cancer and Healthy Participants

Who this might be right for
Pancreatic Cancer
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 88
Early research (Phase 1)Study completedNCT00019513
What this trial is testing

Combination Chemotherapy in Treating Patients With Recurrent, Refractory, or Metastatic Solid Tumors or Lymphomas

Who this might be right for
Colorectal CancerEsophageal CancerExtrahepatic Bile Duct Cancer+7 more
National Institutes of Health Clinical Center (CC) 108
Not applicableNot Yet RecruitingNCT07803770
What this trial is testing

EUS-Based Artificial Intelligence to Predict Outcomes in Pancreatic Cancer

Who this might be right for
Pancreatic NeoplasmsPancreatic Ductal Adenocarcinoma (PDAC)Artificial Intelligence (AI)+2 more
IRCCS San Raffaele 700
Testing effectiveness (Phase 2)Study completedNCT04896073
What this trial is testing

Superenhancer Inhibitor Minnelide in Advanced Refractory Adenosquamous Carcinoma of the Pancreas (ASCP)

Who this might be right for
Adenosquamous Carcinoma of the Pancreas
National Cancer Institute (NCI) 16
Not applicableLooking for participantsNCT07408505
What this trial is testing

Nano-Megestrol Acetate for Cancer Cachexia in Advanced Pancreatic Cancer

Who this might be right for
Advanced Pancreatic Ductal AdenocarcinomaCancer Anorexia-Cachexia Syndrome
Shandong Cancer Hospital and Institute 56
Testing effectiveness (Phase 2)Study completedNCT01416662
What this trial is testing

Gemcitabine Hydrochloride in Treating Patients With Pancreatic Cancer That Has Been Removed by Surgery

Who this might be right for
Pancreatic Cancer
Federation Francophone de Cancerologie Digestive 120
Testing effectiveness (Phase 2)Looking for participantsNCT06895031
What this trial is testing

Study of JYP0015 in Patients With Advanced Solid Tumors Harboring Specific Mutations in RAS

Who this might be right for
Solid TumorPancreatic Ductal Adenocarcinoma (PDAC)Non-small Cell Lung Cancer (NSCLC)+1 more
Guangzhou JOYO Pharma Co., Ltd 210
Testing effectiveness (Phase 2)Ended earlyNCT00003531
What this trial is testing

Antineoplaston Therapy in Treating Patients With Stage IV Pancreatic Cancer

Who this might be right for
Stage IV Pancreatic Cancer
Burzynski Research Institute 15
Testing effectiveness (Phase 2)Ended earlyNCT04992507
What this trial is testing

Impact of Total Intravenous Anesthesia Following Cancer Surgery, TIVACS Study

Who this might be right for
Pancreatic Adenocarcinoma
Ohio State University Comprehensive Cancer Center 8
Testing effectiveness (Phase 2)Active Not RecruitingNCT04539808
What this trial is testing

NeoOPTIMIZE: Early Switching of mFOLFIRINOX or Gemcitabine/Nab-Paclitaxel Before Surgery for the Treatment of Resectable, Borderline Resectable, or Locally-Advanced Unresectable Pancreatic Cancer

Who this might be right for
Pancreatic AdenocarcinomaStage 0 Pancreatic Cancer American Joint Committee on Cancer v8Stage I Pancreatic Cancer American Joint Committee on Cancer v8+2 more
OHSU Knight Cancer Institute
Not applicableStudy completedNCT05048810
What this trial is testing

Clinical Application of 68Ga-DOTA-NT-20.3 in the Early Diagnosis of Pancreatic Ductal Adenocarcinoma

Who this might be right for
Pancreatic Ductal Adenocarcinoma
Nanjing First Hospital, Nanjing Medical University 6
Large-scale testing (Phase 3)Study completedNCT00634725
What this trial is testing

Gemcitabine With or Without Capecitabine and/or Radiation Therapy or Gemcitabine With or Without Erlotinib in Treating Patients With Locally Advanced Pancreatic Cancer That Cannot Be Removed by Surgery

Who this might be right for
Pancreatic Cancer
GERCOR - Multidisciplinary Oncology Cooperative Group 820
Testing effectiveness (Phase 2)Study completedNCT00003591
What this trial is testing

Radiation Therapy Plus Paclitaxel in Treating Patients With Nonmetastatic, Unresectable Pancreatic Cancer

Who this might be right for
Pancreatic Cancer
Radiation Therapy Oncology Group 122
Not applicableLooking for participantsNCT06065891
What this trial is testing

Para-aortic Lymph Node Metastasis in Resectable Pancreatic Cancer

Who this might be right for
Pancreas CancerPancreas AdenocarcinomaLymph Node Metastasis
Jon Unosson 300
Large-scale testing (Phase 3)Study completedNCT00016380
What this trial is testing

Ondansetron With/Out Dexamethasone to Prevent Vomiting in Patients Receiving Radiation to the Upper Abdomen

Who this might be right for
Cancer
NCIC Clinical Trials Group 211
Not applicableEnded earlyNCT01303159
What this trial is testing

Endoscopic Bipolar Radiofrequency Probe (ENDOHPB) in the Management of Unresectable Bile Duct and Pancreatic Cancer

Who this might be right for
CholangiocarcinomaPancreatic Cancer
Weill Medical College of Cornell University 29
Testing effectiveness (Phase 2)Study completedNCT01128296
What this trial is testing

Study of Pre-surgery Gemcitabine + Hydroxychloroquine (GcHc) in Stage IIb or III Adenocarcinoma of the Pancreas

Who this might be right for
Pancreatic Cancer
Amer Zureikat 35
Testing effectiveness (Phase 2)Study completedNCT00003810
What this trial is testing

Combination Chemotherapy in Treating Patients With Locally Advanced or Metastatic Cancer of the Pancreas

Who this might be right for
Pancreatic Cancer
Eastern Cooperative Oncology Group
Testing effectiveness (Phase 2)Looking for participantsNCT03384238
What this trial is testing

Panitumumab-IRDye800 in Patients With Pancreatic Cancer Undergoing Surgery

Who this might be right for
Pancreatic Adenocarcinoma
George Poultsides 27
Testing effectiveness (Phase 2)WithdrawnNCT02310971
What this trial is testing

Cvac as Maintenance Treatment Patients With Resected Stage I or Stage II Adenocarcinoma (Cancer) of the Pancreas

Who this might be right for
Pancreatic Carcinoma Stage IPancreatic Carcinoma Stage II
Prima BioMed Ltd
Next Page
42